Sutro Biopharma, Inc. (STRO) Financials
STRO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 431.7 million | 319.4 million |
2023-06-30 | 464.9 million | 310.2 million |
2023-03-31 | 358.0 million | 172.6 million |
2022-12-31 | 406.9 million | 189.9 million |
STRO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -33.8 million | 6.0 million |
2023-06-30 | -32.8 million | 6.7 million |
2023-03-31 | -61.9 million | 6.0 million |
2022-12-31 | -27.2 million | 5.9 million |
STRO Net Income
No data available :(
STRO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 355.2 million | - | 31.0 million |
2023-06-30 | 391.6 million | - | 32.5 million |
2023-03-31 | 276.5 million | - | 33.3 million |
2022-12-31 | 334.4 million | - | 34.2 million |
STRO Shares Outstanding
STRO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 328000 | 45.7 million | 15.3 million | - |
2023-06-30 | 1.6 million | 41.6 million | 15.0 million | - |
2023-03-31 | 942000 | 39.4 million | 15.5 million | - |
2022-12-31 | 3.4 million | 43.1 million | 14.7 million | - |
STRO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 16.9 million | 1.7 million |
2023-06-30 | 10.4 million | 2.4 million |
2023-03-31 | 12.7 million | 2.3 million |
2022-12-31 | 8.6 million | 2.2 million |
STRO
Price: $4.24
52 week price:
Earnings Per Share: -1.78 USD
P/E Ratio: -1.61
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 223541
Market Capitalization: 313.2 million